Madrigal Pharmaceuticals Inc — Liquidità Trimestrale (NASDAQ:MDGL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 1.04 B996.63 M1.02 B1.36 B1.26 B Totale passività 287.86 M285.99 M319.4 M736.73 M656.9 M Patrimonio netto totale 754.38 M710.64 M695.98 M625.73 M602.69 M Totale passività e patrimonio netto 1.04 B996.63 M1.02 B1.36 B1.26 B Debito totale 117.57 M118 M118.38 M339.75 M339.88 M Indebitamento netto -813.68 M-730.06 M-683.65 M-775 M-643.68 M

Notizie

Wolfe Research conferma rating Peerperform su azioni Madrigal

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH

Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

EVP di Madrigal Pharmaceuticals Dier vende azioni per 854.000$

Madrigal Pharmaceuticals EVP Dier sells $854k in stock

Il CEO di Madrigal Pharmaceuticals Sibold vende azioni per 718k$

Madrigal Pharmaceuticals CEO Sibold sells $718k in shares